Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South Korea
ConclusionThis active safety surveillance study confirms that QIV is well tolerated in children aged 6 –35 months in routine clinical practice in South Korea. There were no safety concerns observed in these young children.
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research
More News: Children | Common Cold | Infectious Diseases | Influenza | Influenza Vaccine | Pain | South Korea Health | Study | Vaccines